Treglia A, Alfano C, Rossini E
Sezione Autonoma di Cardiologia, Presidio Ospedaliero di Formia, Regione Lazio, USL LT/6, Latina.
Minerva Cardioangiol. 1994 Jun;42(6):293-7.
The effectiveness of propafenone versus amiodarone for conversion to sinus rhythm of paroxysmal atrial fibrillation was compared. Fifty-four consecutive adult patients affected by recent onset atrial fibrillation (< 7 days) were randomized to treatment with intravenous propafenone (27 patients) and amiodarone (27 patient). Sinus rhythm was restored respectively in 74.1% and 70.4% (p = ns); within 5 hours was obtained reconversion in 65% of propafenone and in 15.8% of amiodarone group (p < 0.05); the mean conversion time was 3.5 and 16.6 hours (p < 0.01). In conclusion propafenone seems to be as effective and safe as amiodarone, but is significantly fast in converting recent onset atrial fibrillation to sinus rhythm.
比较了普罗帕酮与胺碘酮转复阵发性心房颤动为窦性心律的有效性。54例近期发作心房颤动(<7天)的成年连续患者被随机分为静脉注射普罗帕酮治疗组(27例患者)和胺碘酮治疗组(27例患者)。窦性心律恢复率分别为74.1%和70.4%(p=无显著性差异);5小时内,普罗帕酮组65%的患者实现转复,胺碘酮组为15.8%(p<0.05);平均转复时间分别为3.5小时和16.6小时(p<0.01)。总之,普罗帕酮似乎与胺碘酮一样有效和安全,但在将近期发作的心房颤动转复为窦性心律方面明显更快。